Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 2c (5-HT2c) receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Serotonin receptor | Get druggable targets OG5_135430 | All targets in OG5_135430 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Serotonin 2c (5-HT2c) receptor | 460 aa | 417 aa | 21.3 % |
Echinococcus multilocularis | g protein coupled receptor | Serotonin 2c (5-HT2c) receptor | 460 aa | 412 aa | 19.9 % |
Echinococcus multilocularis | neuropeptides capa receptor | Serotonin 2c (5-HT2c) receptor | 460 aa | 408 aa | 20.8 % |
Echinococcus granulosus | g protein coupled receptor | Serotonin 2c (5-HT2c) receptor | 460 aa | 412 aa | 19.7 % |
Echinococcus granulosus | g protein coupled receptor | Serotonin 2c (5-HT2c) receptor | 460 aa | 409 aa | 21.8 % |
Echinococcus multilocularis | g protein coupled receptor | Serotonin 2c (5-HT2c) receptor | 460 aa | 409 aa | 21.5 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Serotonin 2c (5-HT2c) receptor | 460 aa | 427 aa | 28.3 % |
Schistosoma japonicum | ko:K04135 adrenergic receptor, alpha 1a, putative | Serotonin 2c (5-HT2c) receptor | 460 aa | 405 aa | 31.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.1584 | 1 | 0.5 |
Onchocerca volvulus | 0.048 | 0 | 0.5 | |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.048 | 0 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.1584 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.1584 | 1 | 0.5 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.1584 | 1 | 0.5 |
Brugia malayi | Serotonin receptor | 0.112 | 0.5796 | 1 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.1584 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = -6.3 | Efficacy (pEC50) was evaluated for 5-HT2C receptor-mediated stimulation of IP3 formation in vitro in choroid plexus of the rat | ChEMBL. | 9276022 |
ED50 (functional) | > 10 mg kg-1 | Induction of penile erection in rats after subcutaneous administration, indicative of 5-HT 2c receptor activation | ChEMBL. | 9276022 |
ED50 (functional) | > 10 mg kg-1 | Induction of penile erection in rats after subcutaneous administration, indicative of 5-HT 2c receptor activation | ChEMBL. | 9276022 |
Efficacy (functional) | = 1 | Intrinsic 5-HT 2c receptor activity as induced IP3 turn-over in vitro in rat choroid plexus | ChEMBL. | 9276022 |
Ki (binding) | = -8.1 | Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]-DOB | ChEMBL. | 9276022 |
Ki (binding) | = -7.2 | Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]-5-HT | ChEMBL. | 9276022 |
Log EC50 (functional) | = 6.3 | Efficacy (pEC50) was evaluated for 5-HT2C receptor-mediated stimulation of IP3 formation in vitro in choroid plexus of the rat | ChEMBL. | 9276022 |
Log Ki (binding) | = 7.2 | Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]-5-HT | ChEMBL. | 9276022 |
Log Ki (binding) | = 8.1 | Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]-DOB | ChEMBL. | 9276022 |
Selectivity ratio (binding) | = 8 | Selectivity ratio was measured as pKi ratio of 5-HT2C to that of 5-HT2A receptor | ChEMBL. | 9276022 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.